DermBiont, Inc.

13 clinical trials · Sponsor

Record	Firm	Date
Randomized Study Using SM-030 Gel for Adults With Melasma (NCT06454747)	DermBiont, Inc.	2024-06-27
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers (NCT06409195)	DermBiont, Inc.	2024-03-25
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis (NCT06108024)	DermBiont, Inc.	2023-11-06
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis (NCT05491603)	DermBiont, Inc.	2023-11-01
Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos (NCT05511948)	DermBiont, Inc.	2022-08-18
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis (NCT05136144)	DermBiont, Inc.	2021-10-19
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel (NCT05253755)	DermBiont, Inc.	2021-10-06
A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor (NCT04937920)	DermBiont, Inc.	2021-03-16
A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis (NCT04315051)	DermBiont, Inc.	2019-09-12
Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo (NCT04192513)	DermBiont, Inc.	2019-05-20
A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis (NCT04152226)	DermBiont, Inc.	2019-02-19

Track DermBiont, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.